Lunch & Learn with Thermo Fisher

WEDNESDAY, November 13th at 12:00 pm

"Enabling Technologies and Services for Faster, More Cost-Effective Research"

Guest Speaker: Mark Federici (Bio Link)

Developing therapies for human disease continues to face obstacles in translating targets and compounds identified, validated andoptimized from in vitro studies to viable targets or efficacious and safe compounds once tested in humans. Here we discuss strategies toincrease the relevance of cell models for these in vitro approaches by using primary cells coupled with various detection technologiesfor use in target identification and/or safety pharmacology. We review the current advances in genome engineering and how to leveragea portfolio of these tools to generate knock-out and knock-in models for use in target or compound identification. We extend thatapproach to its use with induced pluripotent stem cells (iPSCSs) to build isogenic disease models, which can be further differentiated tovarious cell types of interest that are more directly related to a disease area than commonly used immortalized cell lines.

In this seminar, we will present an executive level overview of Thermo Fisher’s Bioscience Division, the biological capabilities andenabling technologies we provide, as well as the services available across our diverse portfolio. We will also highlight our emerging 3Dportfolio which contains cells, medias, scaffolds and instrumentation to support your organoid and spheroid culture R&D efforts.

You may also sign up in advance for Office Hours, which will be held immediately following the group discussion. Office Hours Registration